Cargando…
A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth
INTRODUCTION: The risk for brain injury manifested as cerebral palsy is higher in very preterm born children than in term. Prenatal administration of magnesium sulfate (MgSO(4)) has been shown to be neuroprotective and reduces the proportion of very preterm born children later diagnosed with cerebra...
Autores principales: | Hellström, Sara, Jonsdotter, Andrea, Jonsson, Maria, Pettersson, Karin, Saltvedt, Sissel, Herbst, Andreas, Ågren, Johan, Ådén, Ulrika, Domellöf, Magnus, Hagberg, Henrik, Carlsson, Ylva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619608/ https://www.ncbi.nlm.nih.gov/pubmed/37680134 http://dx.doi.org/10.1111/aogs.14673 |
Ejemplares similares
-
Maternal and fetal serum concentrations of magnesium after administration of a 6‐g bolus dose of magnesium sulfate (MgSO(4)
) to women with imminent preterm delivery
por: Jonsdotter, Andrea, et al.
Publicado: (2022) -
Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy
por: Rocha-Ferreira, Eridan, et al.
Publicado: (2018) -
Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants
por: Bouet, Pierre-Emmanuel, et al.
Publicado: (2015) -
Role of magnesium sulfate in neuroprotection in acute ischemic stroke
por: Singh, Harpreet, et al.
Publicado: (2012) -
Magnesium sulfate and fetal neuroprotection: overview of clinical evidence
por: Chollat, Clément, et al.
Publicado: (2018)